We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2),
This study is also in vitro. It does not prove that the much smaller doses you can give to a person would be effective. This study was published in April 2020. Subsequent double-blind tests with patients showed the ivermectin does not work.